Table 2 Baseline characteristics of study population
Variable | Data | ||
|---|---|---|---|
ISR ≥70% | No ISR | p value | |
N | 10 | 50 | |
Age, years | 69.8 ± 7.6 | 68.2 ± 8.7 | 0.580 |
Female sex | 4 (40%) | 8 (16%) | 0.101 |
Right side | 6 (60%) | 19 (38%) | 0.294 |
Symptomatic carotid stenosis | 4 (40%) | 32 (64%) | 0.178 |
Stroke | 2 (20%) | 21 (42%) | 0.291 |
Hemispherical TIA | 2 (20%) | 10 (20%) | 1.000 |
Arterial Hypertension | 10 (100%) | 48 (96%) | 1.000 |
Hyperlipidemia | 10 (100%) | 36 (72%) | 0.098 |
Tobacco use | 4 (40.0%) | 13 (26%) | 0.448 |
Diabetes mellitus | 2 (20%) | 11 (22%) | 1.000 |
Coronary artery disease | 3 (30%) | 16 (32%) | 1.000 |
Peripheral occlusive arterial disease | 3 (30%) | 7 (14%) | 0.347 |
Atrial fibrillation | 1 (12.5%) | 3 (6%) | 0.528 |
CEA restenosis | 3 (30%) | 6 (12%) | 0.163 |
Contralateral ICA occlusion | 3 (30%) | 7 (14%) | 0.347 |
Contralateral ICA stenosis ≥70% | 2 (20%) | 13 (26%) | 1.000 |
Stenosis ≥ 90% before CAS | 7 (70%) | 22 (44%) | 0.175 |
Median follow-up time (month, IQR) | 15 (4.7 - 35.4) | 40.2 (26.7 – 59.3) | 0.024* |
PSV >120 cm/s after CAS | 4 (40%) | 3 (6%) | 0.012 |
Re-interventions | 6 (60%) | 0 (0%) | <0.001 |